Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  lomustine
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-13 of 13 for your search:
Start Over
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: At least 3 to 5 years to under 22 years
Sponsor: Other
Protocol IDs: SIOP PNET 5 MB, 2011-004868-30, NCT02066220
P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: Tg 511-15-01, NCT02414165
gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: P130097, NCT02444000
Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CBKM120E2102, 2013-003129-27, NCT01934361
Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 3 to 30 at initial diagnosis
Sponsor: Other
Protocol IDs: CDR0000069075, CHP-693, CHP-IRB-2001-12-2301, NCI-V01-1680, NCT00031590
Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GFPC 05-01, NCT00418743
Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: 00591, Eudract: 2008-007645-31, NCT00989352
Procarbazine and Lomustine in Recurrent Glioblastoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: KNOG-1201, NCT01737346
Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AMC-068, NCI-2012-01695, U01CA121947, NCT01775475
ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: M14-483, 2014-004438-24, EORTC 1410-BTG, NCT02343406
Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: 3 to 18
Sponsor: Other
Protocol IDs: J1403, NA_00091840, NCT02212574
A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation
Phase: No phase specified
Type: Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: YDCR-2014-006, ChiCTR-OOC-15005759, NCT02333513
Start Over